At a glance
- Originator Aventis
- Class Neuroprotectants; Nootropics
- Mechanism of Action Acetylcholine stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 25 Jun 1996 Discontinued-I for Cognition disorders in Germany (Unknown route)